Aclaris Therapeutics, Inc. 4
4 · Aclaris Therapeutics, Inc. · Filed Jun 16, 2017
Insider Transaction Report
Form 4
Bierly Rick
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-15+8,000→ 8,000 totalExercise: $24.58Exp: 2027-06-14→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in twelve equal monthly installments through June 15, 2018, subject to the reporting person's continuous service as of such vesting date.